PL3438096T3 - Sposób wytwarzania 1-(arylometylo)chinazolino-2,4(1H,3H)-dionu - Google Patents

Sposób wytwarzania 1-(arylometylo)chinazolino-2,4(1H,3H)-dionu

Info

Publication number
PL3438096T3
PL3438096T3 PL17773281T PL17773281T PL3438096T3 PL 3438096 T3 PL3438096 T3 PL 3438096T3 PL 17773281 T PL17773281 T PL 17773281T PL 17773281 T PL17773281 T PL 17773281T PL 3438096 T3 PL3438096 T3 PL 3438096T3
Authority
PL
Poland
Prior art keywords
arylmethyl
quinazoline
dione
manufacturing process
manufacturing
Prior art date
Application number
PL17773281T
Other languages
English (en)
Inventor
Suixiong Cai
Ping Huang
Original Assignee
Impact Therapeutics, Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Impact Therapeutics, Inc filed Critical Impact Therapeutics, Inc
Publication of PL3438096T3 publication Critical patent/PL3438096T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96—Two oxygen atoms
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL17773281T 2016-04-01 2017-03-31 Sposób wytwarzania 1-(arylometylo)chinazolino-2,4(1H,3H)-dionu PL3438096T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201610202881 2016-04-01
PCT/CN2017/078913 WO2017167251A1 (zh) 2016-04-01 2017-03-31 1-(芳基甲基)喹唑啉-2,4(1h,3h)-二酮的制备工艺
EP17773281.5A EP3438096B1 (en) 2016-04-01 2017-03-31 Manufacturing process for 1-(arylmethyl) quinazoline-2,4 (1h, 3h)-dione

Publications (1)

Publication Number Publication Date
PL3438096T3 true PL3438096T3 (pl) 2021-05-17

Family

ID=59963547

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17773281T PL3438096T3 (pl) 2016-04-01 2017-03-31 Sposób wytwarzania 1-(arylometylo)chinazolino-2,4(1H,3H)-dionu

Country Status (13)

Country Link
US (1) US10562889B2 (pl)
EP (1) EP3438096B1 (pl)
CN (1) CN109153652B (pl)
CY (1) CY1123898T1 (pl)
DK (1) DK3438096T3 (pl)
ES (1) ES2859460T3 (pl)
HR (1) HRP20210328T1 (pl)
HU (1) HUE053554T2 (pl)
PL (1) PL3438096T3 (pl)
PT (1) PT3438096T (pl)
RS (1) RS61556B1 (pl)
SI (1) SI3438096T1 (pl)
WO (1) WO2017167251A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230263801A1 (en) * 2020-07-24 2023-08-24 Impact Therapeutics (Shanghai), Inc Combination therapy of parp inhibitors
WO2022099442A1 (zh) * 2020-11-10 2022-05-19 上海瑛派药业有限公司 5-氟-1-(4-氟-3-(4-(嘧啶-2-基)哌嗪-1-羰基)苄基)喹唑啉-2,4(1h,3h)-二酮的结晶形式及其制备
KR20230163467A (ko) 2021-03-26 2023-11-30 임팩트 테라퓨틱스 (상하이), 인코포레이티드 Parp 억제제의 경구 캡슐 및 이의 제조 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004087680A1 (en) * 2003-03-31 2004-10-14 Taisho Pharmaceutical Co., Ltd. Novel quinazoline derivatives and methods of treatment related to the use thereof
SG154432A1 (en) * 2004-06-30 2009-08-28 Janssen Pharmaceutica Nv Quinazolinedione derivatives as parp inhibitors
WO2006028904A1 (en) * 2004-09-02 2006-03-16 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
CN101475537A (zh) * 2009-01-07 2009-07-08 太仓市浦源化工有限公司 一种2,4-二氯喹唑啉的制备方法
EP2686305B1 (en) * 2011-03-14 2020-09-16 Impact Therapeutics, Inc. Quinazolinediones and their use
TWI527800B (zh) * 2011-04-01 2016-04-01 南京英派藥業有限公司 作為聚（二磷酸腺苷酸－核醣）聚合酶（ｐａｒｐ）之抑制劑之１－（芳基甲基）喹唑啉－２，４（１ｈ，３ｈ）－二酮及其應用
US9102631B2 (en) * 2011-11-01 2015-08-11 Impact Therapeutics, Inc. 1-(arylmethyl)-5,6,7,8-tetrahydroquinazoline-2,4-diones and analogs and the use thereof
WO2016155655A1 (zh) * 2015-04-03 2016-10-06 上海瑛派药业有限公司 Parp抑制剂固体药物剂型及其应用
US20180370981A1 (en) * 2015-12-21 2018-12-27 Idemitsu Kosan Co., Ltd. Hetero-condensed phenylquinazolines and their use in electronic devices

Also Published As

Publication number Publication date
RS61556B1 (sr) 2021-04-29
EP3438096B1 (en) 2020-12-02
SI3438096T1 (sl) 2021-04-30
CN109153652A (zh) 2019-01-04
US10562889B2 (en) 2020-02-18
HRP20210328T1 (hr) 2021-04-02
US20190112298A1 (en) 2019-04-18
WO2017167251A1 (zh) 2017-10-05
EP3438096A1 (en) 2019-02-06
PT3438096T (pt) 2021-03-03
CY1123898T1 (el) 2022-05-27
EP3438096A4 (en) 2019-08-21
ES2859460T3 (es) 2021-10-04
HUE053554T2 (hu) 2021-07-28
DK3438096T3 (da) 2021-02-22
CN109153652B (zh) 2021-07-27

Similar Documents

Publication Publication Date Title
ZA202004692B (en) Processes for preparing (1 -(3-fluoro-2-(trifluoromethyl)isonicotinyl)piperidine-4-one)
GB2571231B (en) Textiles and articles, and processes for making the same
IL257442A (en) Process for preparing parp inhibitor, crystalline forms and their uses
ZA201901870B (en) Process for producing nonwoven
SI3227297T1 (sl) 4,6-substituirani-pirazolo(1,5-A)pirazini kot inhibitorji Janus kinaze
PT3290418T (pt) Inibidores de janus quinase (jak)
IL292429B2 (en) An improved process for the preparation of aminopyrimidine derivatives
IL255386A0 (en) Processes and building materials for the preparation of {1-(ethylsulfonyl)-3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]azetidin-3-yl}acetonitrile
MX2015005188A (es) Proceso mejorado para la elaboracion de 5-(2, 6-di-4-morfolinil-4-pirimidinil)-4-trifluoro-metil-piridin-2-amin a.
HUE054849T2 (hu) Eljárás formaldehid-stabilizált karbamid gyártására
IL248272A0 (en) A new manufacturing process for triazine, pyrimidine and pyridine derivatives
IL262534B (en) A method for the production of 5-hydroxyalkyl substituted 1-phenyl-4,2,1-triazole derivatives
HUE053554T2 (hu) Eljárás 1-(arilmetil)-kinazolin-2,4-(1H, 3H)-dion elõállítására
SI3880802T1 (sl) Izboljšan postopek za proizvodnjo celic T
ZA201805791B (en) 5-methyl-6-phenyl-4,5-dihydro-2h-pyridazin-3-one derivative
GB2572354B (en) Novel electrochemical set-up for ammonia production
SI3621966T1 (sl) Derivati pirazol(1,5-A)pirimidina kot kinazni JAK inhibitorji
PT3362496T (pt) Método para controlar o processo para preparar isocianatos
HK1215759B (en) Electrolyte forming process
HK1228106B (en) Electrolyte forming process